Granules India receives FDA approval for generic ADHD drug, expanding portfolio and reinforcing presence in treatment space.

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...

ROCKVILLE, Md. - Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company specializing in CNS diseases with an impressive 89% gross profit margin, has announced the FDA approval of a ...

Granules strengthens ADHD portfolio with US FDA approval for lisdexamfetamine dimesylate capsules: Our Bureau, Bengaluru Thursday, January 30, 2025, 16:15 Hrs [IST] Granules India ...

“Our findings suggest that the Adderall shortage did not cause many children to stop stimulant therapy altogether, but it did ...

Hyderabad: Granules India Limited, a vertically integrated Indian pharmaceutical company, has announced that its wholly-owned ...

For example, people with ADHD might forget to take medications for diabetes or to make follow-up appointments with their ...

A national shortage in a common treatment for attention-deficit hyperactivity disorder was associated with changes in stimulant prescriptions filled for children over recent years, a new study ...

Is the shortage of ADHD drugs, especially Adderall, forcing children to constantly switch medications?In a new study, researchers compared stimulant rates for k ...